VIELA BIO
Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. The Company’s portfolio selectively targets shared critical pathways that are the root cause of disease. Led by a team of global leaders in inflammation and autoimmunity, Viela Bio strives to be a fully integrated biotechnology company, helping millions of patients worldwide. Viela Bio is located in Gaithersburg, Maryland.
VIELA BIO
Industry:
Biopharma Biotechnology Health Diagnostics Medical Wellness
Founded:
2017-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.vielabio.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
526.25 M USD
Technology used in webpage:
Domain Not Resolving Content Delivery Network Amazon Google Google Cloud Google Maps API Pound Sterling Amazon Virginia Region Ruby On Rails Token OSS CDN
Similar Organizations
Alzamend Neuro
Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Clementia Pharmaceuticals
Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders.
Georgiamune
Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.
Fore Biotherapeutics
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Sapience Therapeutics
Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs
Current Employees Featured
Stock Details
Investors List
HBM Healthcare Investments
HBM Healthcare Investments investment in Series B - Viela Bio
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Viela Bio
Viking Global Investors
Viking Global Investors investment in Series B - Viela Bio
Barer & Son Capital
Barer & Son Capital investment in Series B - Viela Bio
Terra Magnum Capital Partners (""""TMCP"""")""
Terra Magnum Capital Partners (""""TMCP"""")"" investment in Series B - Viela Bio
Goldman Sachs
Goldman Sachs investment in Series B - Viela Bio
Temasek Holdings
Temasek Holdings investment in Series B - Viela Bio
Temasek Holdings
Temasek Holdings investment in Series A - Viela Bio
Hillhouse Investment
Hillhouse Investment investment in Series A - Viela Bio
Sirona Capital
Sirona Capital investment in Series A - Viela Bio
Official Site Inspections
http://www.vielabio.com
- Host name: 55.149.196.35.bc.googleusercontent.com
- IP address: 35.196.149.55
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Viela Bio"
Viela Bio - Crunchbase Company Profile & Funding
Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. The Company’s portfolio selectively targets shared critical pathways that are the root cause of …See details»
Horizon acquires Viela for $3bn to drive innovation …
Feb 9, 2021 · Horizon has agreed to buy Viela for $3bn to expand its pipeline, as well as drive long-term growth. Viela has an extensive portfolio of medicines for autoimmune and inflammatory diseases, which Horizon plans to explore more …See details»
Horizon acquires Viela Bio for $3B in a windfall for …
Feb 1, 2021 · Horizon Therapeutics has agreed to acquire Viela Bio, a spinout of AstraZeneca, in a deal that values the Maryland-based biotech at roughly $3 billion. Horizon will pay $53 per share for Viela, which in June won U.S. …See details»
Viela Bio - PitchBook
Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatments for severe inflammation and autoimmune diseases. Its lead molecule inebilizumab, is a humanized …See details»
Viela Bio, Inc. - AnnualReports.com
Viela Bio, headquartered in Gaithersburg, Maryland, is a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune and severe inflammatory diseases. Viela Bio, Inc. …See details»
Viela Bio Company Profile - Office Locations, Competitors ... - Craft
Viela Bio is a clinical-stage biotechnology company advancing treatments for severe inflammation and autoimmune diseases by selectively targeting shared critical pathways that are the root …See details»
Horizon Pharma acquires Viela Bio - 2021-02-01 - Crunchbase
Feb 1, 2021 · Viela Bio Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. Acquiring …See details»
Horizon Therapeutics plc Completes Acquisition of Viela Bio, Inc.
Mar 15, 2021 · DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has completed the acquisition of Viela Bio, Inc. (Nasdaq: VIE) (“Viela”).See details»
Horizon Therapeutics acquires Viela Bio in a 3.05B Deal to expand …
Companies Overview { Viela Bio Viela Bio is a young but promising company focused on developing medicines for patients with a wide range of autoimmune and severe in ammatory …See details»
Horizon Therapeutics plc to Acquire Viela Bio, Inc. to …
Feb 1, 2021 · DUBLIN & GAITHERSBURG, Md.--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) and Viela Bio, Inc. (Nasdaq: VIE) today announced the companies have entered into a definitive agreement...See details»
Viela Bio, Inc. Company Profile | Gaithersburg, MD | Competitors ...
Find company research, competitor information, contact details & financial data for Viela Bio, Inc. of Gaithersburg, MD. Get the latest business insights from Dun & Bradstreet.See details»
Viela Bio Announces U.S. FDA Approval of UPLIZNA™
GAITHERSBURG, Md., June 11, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq: VIE) today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNATM …See details»
AstraZeneca agrees to divest Viela shareholding
Feb 1, 2021 · AstraZeneca has agreed, subject to certain limited exceptions, to divest its 26.7% ownership in Viela Bio, Inc. (Viela), as part of the proposed acquisition of Viela by Horizon …See details»
Horizon Therapeutics to Acquire Viela Bio to Grow Rare Disease
San Diego – February 5, 2021 – Cooley advised Horizon Therapeutics on its agreement to acquire Viela Bio, under which Horizon will acquire all of the issued and outstanding shares of …See details»
Viela Bio Reports Fourth Quarter and Full Year 2020 Operating and ...
Mar 1, 2021 · --Viela Bio, a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for patients suffering from autoimmune and severe …See details»
Horizon Therapeutics plc Completes Acquisition of Viela Bio, Inc.
DUBLIN – Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has completed the acquisition of Viela Bio, Inc. (Nasdaq: VIE) (“Viela”).See details»
Viela Bio Reports Fourth Quarter and Full Year 2020 Operating and ...
GAITHERSBURG, Md., March 01, 2021 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a biotechnology company dedicated to the discovery, development and commercialization of …See details»
Viela Bio CEO and Key Executive Team | Craft.co
Viela Bio's Chairman and Chief Executive Officer is Bing Yao. Other executives include Mitchell Chan, Chief Financial Officer; Edward Hu, Director and 11 others. See the full leadership team …See details»
Viela Bio Inc (VIE-Q) Stock Price and News - The Globe and Mail
Viela Bio Inc. is a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases. Viela Bio Inc. is headquartered in Gaithersburg, Maryland.See details»
AstraZeneca spinoff Viela Bio scored its first FDA nod. Can it face ...
Jun 15, 2020 · Two years after launching, AstraZeneca spinoff Viela Bio has its first FDA approval in Uplizna following Friday's nod to treat certain patients with neuromyelitis optica spectrum …See details»